BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11332776)

  • 1. Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses.
    Kida E; Golabek AA; Wisniewski KE
    Adv Genet; 2001; 45():35-68. PubMed ID: 11332776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry of neuronal ceroid lipofuscinoses.
    Junaid MA; Pullarkat RK
    Adv Genet; 2001; 45():93-106. PubMed ID: 11332778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
    Mole SE; Mitchison HM; Munroe PB
    Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular genetic basis of the neuronal ceroid lipofuscinoses.
    Gardiner RM
    Neurol Sci; 2000; 21(3 Suppl):S15-9. PubMed ID: 11073223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic spectrum of human neuronal ceroid-lipofuscinoses.
    Mole SE
    Brain Pathol; 2004 Jan; 14(1):70-6. PubMed ID: 14997939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal ceroid lipofuscinoses caused by defects in soluble lysosomal enzymes (CLN1 and CLN2).
    Hofmann SL; Atashband A; Cho SK; Das AK; Gupta P; Lu JY
    Curr Mol Med; 2002 Aug; 2(5):423-37. PubMed ID: 12125808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses.
    Mole SE; Williams RE; Goebel HH
    Neurogenetics; 2005 Sep; 6(3):107-26. PubMed ID: 15965709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal ceroid lipofuscinoses: classification and diagnosis.
    Wisniewski KE; Kida E; Golabek AA; Kaczmarski W; Connell F; Zhong N
    Adv Genet; 2001; 45():1-34. PubMed ID: 11332767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuronal ceroid-lipofuscinoses.
    Bennett MJ; Rakheja D
    Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical aspects of neuronal ceroid lipofuscinoses.
    Tyynelä J; Suopanki J
    Neurol Sci; 2000; 21(3 Suppl):S21-5. PubMed ID: 11073224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins.
    Kyttälä A; Lahtinen U; Braulke T; Hofmann SL
    Biochim Biophys Acta; 2006 Oct; 1762(10):920-33. PubMed ID: 16839750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal ceroid lipofuscinoses and possible pathogenic mechanism.
    Zhong N
    Mol Genet Metab; 2000; 71(1-2):195-206. PubMed ID: 11001811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
    Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal ceroid lipofuscinoses are connected at molecular level: interaction of CLN5 protein with CLN2 and CLN3.
    Vesa J; Chin MH; Oelgeschläger K; Isosomppi J; DellAngelica EC; Jalanko A; Peltonen L
    Mol Biol Cell; 2002 Jul; 13(7):2410-20. PubMed ID: 12134079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3.
    Chattopadhyay S; Pearce DA
    Mol Genet Metab; 2000; 71(1-2):207-11. PubMed ID: 11001812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome.
    Sleat DE; Wiseman JA; El-Banna M; Zheng H; Zhao C; Soherwardy A; Moore DF; Lobel P
    Mol Cell Proteomics; 2019 Nov; 18(11):2244-2261. PubMed ID: 31501224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease.
    Weimer JM; Kriscenski-Perry E; Elshatory Y; Pearce DA
    Neuromolecular Med; 2002; 1(2):111-24. PubMed ID: 12025857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers.
    Sleat DE; Tannous A; Sohar I; Wiseman JA; Zheng H; Qian M; Zhao C; Xin W; Barone R; Sims KB; Moore DF; Lobel P
    J Proteome Res; 2017 Oct; 16(10):3787-3804. PubMed ID: 28792770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function.
    Getty AL; Pearce DA
    Cell Mol Life Sci; 2011 Feb; 68(3):453-74. PubMed ID: 20680390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse gene knockout models for the CLN2 and CLN3 forms of ceroid lipofuscinosis.
    Katz ML; Johnson GS
    Eur J Paediatr Neurol; 2001; 5 Suppl A():109-14. PubMed ID: 11588979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.